Your browser doesn't support javascript.
loading
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme.
Bain, Stephen C; Hansen, Brian B; Malkin, Samuel J P; Nuhoho, Solomon; Valentine, William J; Chubb, Barrie; Hunt, Barnaby; Capehorn, Matthew.
Affiliation
  • Bain SC; Institute of Life Science, Swansea University Medical School, Singleton Park, Swansea, UK.
  • Hansen BB; Novo Nordisk A/S, Vandtårnsvej 108, 2860, Søborg, Denmark.
  • Malkin SJP; Ossian Health Economics and Communications, Bäumleingasse 20, 4051, Basel, Switzerland.
  • Nuhoho S; Novo Nordisk A/S, Vandtårnsvej 108, 2860, Søborg, Denmark.
  • Valentine WJ; Ossian Health Economics and Communications, Bäumleingasse 20, 4051, Basel, Switzerland.
  • Chubb B; Novo Nordisk Ltd., 3 City Place, Beehive Ring Road, Gatwick, UK.
  • Hunt B; Ossian Health Economics and Communications, Bäumleingasse 20, 4051, Basel, Switzerland. hunt@ossianconsulting.com.
  • Capehorn M; Rotherham Institute of Obesity, Clifton Medical Centre, Doncaster Gate, Rotherham, UK.
Diabetes Ther ; 11(1): 259-277, 2020 Jan.
Article in En | MEDLINE | ID: mdl-31833042
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Language: En Journal: Diabetes Ther Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Language: En Journal: Diabetes Ther Year: 2020 Document type: Article Affiliation country: Country of publication: